Cell Impact begins the exercise period for TO5 warrants, setting the price at 0.05 SEK per share, with the window open until November 20, 2026.
The exercise price for the TO5 warrants was set at 0.05 SEK per share, the floor set at quota value, after the volume-weighted average share price during 26 October to 6 November 2026 was only 0.021 SEK. Exercising therefore costs more than the shares trade for, making exercise unlikely, and the up to 279,913,506 new shares (~14.0 MSEK before issue costs) are unlikely to be issued. This is a routine, largely administrative warrant announcement with no earnings, order or guidance content.
Cell Impact has initiated the exercise period for its TO5 series warrants, running from November 9 to November 20, 2026. The exercise price has been fixed at 0.05 SEK per share, matching the quota value, following a volume-weighted average share price of 0.021 SEK during the measurement period.
0.05 SEK per new share, set as 70 percent of the volume-weighted average share price during 26 October to 6 November 2026 but floored at the quota value of 0.05 SEK.
From 9 November 2026 to 20 November 2026; the last day to trade the TO5 warrants is 18 November 2026, and some banks may have an earlier cutoff.